# reload+after+2024-01-21 05:45:22.579620
address1§One IDEXX Drive
city§Westbrook
state§ME
zip§04092
country§United States
phone§207 556 0300
fax§207 556 4346
website§https://www.idexx.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
fullTimeEmployees§11000
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Jonathan J. Mazelsky', 'age': 62, 'title': 'President, CEO & Director', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 2038099, 'exercisedValue': 15145850, 'unexercisedValue': 42224584}, {'maxAge': 1, 'name': 'Mr. Brian P. McKeon', 'age': 61, 'title': 'CFO, Executive VP & Treasurer', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 1060641, 'exercisedValue': 258686, 'unexercisedValue': 15451343}, {'maxAge': 1, 'name': 'Mr. James F. Polewaczyk', 'age': 59, 'title': 'Executive VP & Chief Commercial Officer', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 889991, 'exercisedValue': 0, 'unexercisedValue': 5444937}, {'maxAge': 1, 'name': 'Mr. Michael J. Lane', 'age': 55, 'title': 'Executive VP and GM of Reference Laboratories & Information Technology', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 891096, 'exercisedValue': 0, 'unexercisedValue': 3617483}, {'maxAge': 1, 'name': 'Dr. Nimrata Khatra Hunt P.E., Ph.D.', 'age': 55, 'title': 'Executive Vice President of Strategy, Sector Development & Global Operations', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 887768, 'exercisedValue': 0, 'unexercisedValue': 2864964}, {'maxAge': 1, 'name': 'Mr. John  Hart', 'title': 'Senior Vice President of Global Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jeffery D. Chadbourne', 'age': 47, 'title': 'Senior Director of Accounting & Financial Reporting', 'yearBorn': 1976, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Martin  Smith Ph.D.', 'age': 55, 'title': 'Executive VP & CTO', 'yearBorn': 1968, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ken  Grady', 'title': 'Senior VP & Chief Information Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Sharon E. Underberg', 'age': 62, 'title': 'Executive VP, General Counsel, & Corporate Secretary', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 881053, 'exercisedValue': 84312, 'unexercisedValue': 319294}]
auditRisk§9
boardRisk§2
compensationRisk§2
shareHolderRightsRisk§9
overallRisk§6
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.271
priceToSalesTrailing12Months§12.438588
currency§USD
dateShortInterest§1702598400
forwardEps§10.94
pegRatio§3.04
exchange§NMS
quoteType§EQUITY
shortName§IDEXX Laboratories, Inc.
longName§IDEXX Laboratories, Inc.
firstTradeDateEpochUtc§677511000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§f576b05b-2a7f-3f70-9980-7b0489373c04
gmtOffSetMilliseconds§-18000000
targetHighPrice§602.0
targetLowPrice§440.0
targetMeanPrice§533.0
targetMedianPrice§535.0
recommendationMean§2.2
recommendationKey§buy
numberOfAnalystOpinions§8
quickRatio§0.88
earningsGrowth§0.177
grossMargins§0.59888
ebitdaMargins§0.33229
trailingPegRatio§5.3024
